Anti-Angiogenetic and Anti-Lymphangiogenic Effects of a Novel 2-Aminobenzimidazole Derivative, MFB

Overview of attention for article published in Frontiers in oncology, June 2022

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age and source (52nd percentile)

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 5 Dimensions

Readers on

mendeley: 4 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 4 X posts from 3 X users, with an upper bound of 7,657 followers.

Anti-Angiogenetic and Anti-Lymphangiogenic Effects of a Novel 2-Aminobenzimidazole Derivative, MFB https://t.co/RrxZQvM7a4

07 Jul 2022

Reply Repost Favourite

New article: Anti-Angiogenetic and Anti-Lymphangiogenic Effects of a Novel 2-Aminobenzimidazole Derivative, MFB https://t.co/CCyoCQeOac #lungcancer #oncology https://t.co/4FTAdjR3SW

07 Jul 2022

Reply Repost Favourite

New article: Anti-Angiogenetic and Anti-Lymphangiogenic Effects of a Novel 2-Aminobenzimidazole Derivative, MFB https://t.co/rcw5uqt1Vp #melanoma #oncology https://t.co/Tj4UHLuvki

07 Jul 2022

Reply Repost Favourite

New research: Anti-Angiogenetic and Anti-Lymphangiogenic Effects of a Novel 2-Aminobenzimidazole Derivative, MFB: Background and Purpose Benzimidazoles have attracted much attention over the last few decades due to their broad-spectrum… https://t.co/sQxYL

20 Jun 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.